Regensburg, September 8, 2008 - GENEART AG, the global leader in gene synthesis and specialist in the field of Synthetic Biology, has announced the founding of a new subsidiary on the west coast of the USA in San Francisco, California. The newly-founded subsidiary GENEART Inc. is located in the San Francisco Bay Area, at the heart of one of the largest biotech clusters in the world. More than 140 listed biotechnology companies in California generate annual sales of approximately USD 44 billion and spend more than USD 12 billion on research and development.* In addition to the large number of biopharmaceutical/biotechnology firms and large research centers, numerous renowned academic research institutions along the west coast of the U.S. are working on the development of new industrial products and therapeutics.
“With our two subsidiaries in Toronto, Canada and San Francisco, U.S., we can now offer optimum support for the largest biotechnology research clusters in North America. This benefits all researchers in the pharmaceutical and biotechnology industries as well as academic institutions working on the development of innovative biopharmaceuticals, vaccines and industrial enzymes. Direct contact to our customers and outstanding customer service are key factors for continued strong growth in North America, our most important foreign market,” says Christian Ehl, CEO of GENEART AG.
For further inquiries, please contact:
Bernd Merkl GENEART AG Josef-Engert-Str. 11 93053 Regensburg Germany Phone: +49-(0)941-942 76-638 Fax: +49-(0)941-942 76-711 ir@geneart.com http://www.geneart.com
Frank Ostermair Better Orange IR & HV AG Haidelweg 48 81241 Munich Germany Phone: +49-(0)89-8896906-10 Fax: +49-(0)89-8896906-66 info@better-orange.de http://www.better-orange.de
